ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1295

Online Consultation for Rheumatic Disease Patients Based on Smart System of Disease Management (SSDM) Mobile Tools: A Study of Medical Economics

Fei Xiao1, Xiangyuan Liu2, Hua Wei3, Zhijun Li4, Yanhong Huang5, Yaohu Jiang6, Huiqiong Zhou7, Jie Shen8, Yuhua Jia1, Li Zhang1, Yuan Liu1, Minjun Wang1 and Fengchun Zhang9, 1Gothic Internet Technology Corporation, Shanghai, China, 2Department of Rheumatology and Immunology, Peking University Third hospital, Bei jing, China, 3No 98,Nantong West Rd,Yangzhou, Northern Jiangsu People's Hospital, Yangzhou, China, 4The First Affiliated Hospital of Bengbu Medical College, Bengbu, China, 5Beijing Jishuitan Hospital, Beijing, China, 6Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai, China, 7The First Affiliated Hospital of PLA General Hospital, Beijing, China, 8University of Rochester, Rochester, NY, 9Department of Rheumatology, Peking Union Medical college Hosptial, Beijing, China

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: consults, Economics, online patient engagement and rheumatic disease

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Health Services Research Poster (ARHP)

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: China has no primary medical care and referral system. Patients can choose any hospitals or any doctors they like to seek medical care. As a result, most patients with rheumatic diseases rushed to a few large cities on their own cost.

Survey shows more than 40% of the rheumatic disease patients are unnecessary to go to hospital and they only need advices from specialist.

Smart System of Disease Management (SSDM) is a series of applications for chronic diseases management, which develop the interaction between doctors and patients online with mobile device. The study shows that, after training, the rheumatoid arthritis (RA) patients can master the SSDM and perform self-management, including DAS28 and HAQ evaluations, as well as medication and lab test data entries.

To evaluate the feasibility and benefit of the medical economics of online consultations based on SSDM by rheumatologists.

Methods: The rheumatologists implemented the education and training programs on using SSDM for rheumatic disease patients and assist them in downloading SSDM APP in clinic.

The SSDM includes doctors’ application and patients’ application. The patient application includes self-assessment (DAS28, HAQ), medication management, adverse events management and laboratory records. After data entry, patients can synchronize data to the authorized doctor. On the basis of understanding of the disease activities, medication and laboratory test results, the rheumatologists can accept the request from their patients and practice consultation in the form of texting or telephone call.

Results: Between February 14, 2015 and June 22, 2015, 8 rheumatologists supplied 55 patients with 64 times free and 12 paid consultations. Paid consulting included 8 times text Q&A and four telephone consultations. The consulting fee ranged from RMB 50 to 300 yuan (USD:RMB =1:6.1) each in average of 220.83 ± 72.17 yuan, which rate match the registration fee in hospital. The total collection of fee for consultations was 2,650 yuan.

75% patients receiving online consultation lived in different city with the rheumatologists, the mean distance was 925.71 ± 803.65 (58 – 3,150) kilometers. If patients seek medical in hospital, in addition to the registration fees and medical expenses, the mean cost of transportation, accommodation, meals and lost wages was 922.37 ± 686.94 (200 – 2,000) yuan. The total of cost for all patients would have been 70,100 yuan, which is 26.45 times compare with the cost of online. Through the SSDM system for online consultations, patients can save 96.22% of the cost. Survey shows all patients were satisfied and 87.5% of them were “very satisfied” with the consultations.

Conclusion: Using SSDM system to obtain online consultation, Chinese patients with rheumatic disease can enjoy reducing cost with high rate of satisfaction. In the era lack of primary care system in China, SSDM may serve a complimentary platform to control medical care cost, as well as relieve the tensions between health care professionals and patients.


Disclosure: F. Xiao, None; X. Liu, None; H. Wei, None; Z. Li, None; Y. Huang, None; Y. Jiang, None; H. Zhou, None; J. Shen, None; Y. Jia, None; L. Zhang, None; Y. Liu, None; M. Wang, None; F. Zhang, None.

To cite this abstract in AMA style:

Xiao F, Liu X, Wei H, Li Z, Huang Y, Jiang Y, Zhou H, Shen J, Jia Y, Zhang L, Liu Y, Wang M, Zhang F. Online Consultation for Rheumatic Disease Patients Based on Smart System of Disease Management (SSDM) Mobile Tools: A Study of Medical Economics [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/online-consultation-for-rheumatic-disease-patients-based-on-smart-system-of-disease-management-ssdm-mobile-tools-a-study-of-medical-economics/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/online-consultation-for-rheumatic-disease-patients-based-on-smart-system-of-disease-management-ssdm-mobile-tools-a-study-of-medical-economics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology